Thursday, September 30, 2010

Novartis Pays $422M For Off-Label Marketing

›
From Pharmalot by Ed Silverman Another week, another drugmaker agrees to settle off-label marketing charges brought by the federal governme...

FDA approves yet another new birth control pill; are they paying attention?

›
The FDA has approved a new birth control pill from Bayer Healthcare Phamaceuticals, Inc. The new pill, which will be marketed as Beyaz, was ...

Maryland Damage Cap Upheld

›
The Maryland Court of Appeals has rejected a challenge to the state’s cap on non-economic damages, which limits the amount of compensation p...

Class action against Abbott for contaminated baby formula

›
A class action lawsuit has been filed against Abbott Laboratories by a mother who says that the company deceptively promoted Similac infant ...

Public Citizen criticizes FDA for not removing Avandia from the market

›
As reported five days ago, the FDA recently decided not to ban the diabetes drug Avandia. In response, Dr. Sidney Wolfe, Director of Public...

Med mal update pt 2

›
Here is a comment from the Tort Deform blog on the contradiction between the fact that diagnostic errors are the leading cause of malpracti...

Med mal reform update

›
The PopTort blog is reporting that the Center for Justice & Democracy has just published two new articles that warn of some serious prob...
Monday, September 27, 2010

What's with all the lawyer shows on tv?!

›
I don't watch a lot of TV, but I try to check out shows about lawyers just in case they raise issues I can discuss in class. There have ...
Saturday, September 25, 2010

FDA decides not to remove Avandia from the market

›
In a move that many anticipated, the FDA is leaving the controversial Avandia diabetes pill on the market, but with restrictions for patient...

Today Show segment on the dangers of birth control patch

›
Last week, the TV show "The Today Show" had a segment on Johnson & Johnson's birth control patch Ortho-Evra that cites cou...